Peng Zhan

2.8k total citations · 1 hit paper
87 papers, 2.1k citations indexed

About

Peng Zhan is a scholar working on Infectious Diseases, Molecular Biology and Virology. According to data from OpenAlex, Peng Zhan has authored 87 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Infectious Diseases, 33 papers in Molecular Biology and 29 papers in Virology. Recurrent topics in Peng Zhan's work include HIV/AIDS drug development and treatment (39 papers), HIV Research and Treatment (29 papers) and Pneumocystis jirovecii pneumonia detection and treatment (12 papers). Peng Zhan is often cited by papers focused on HIV/AIDS drug development and treatment (39 papers), HIV Research and Treatment (29 papers) and Pneumocystis jirovecii pneumonia detection and treatment (12 papers). Peng Zhan collaborates with scholars based in China, Belgium and United States. Peng Zhan's co-authors include Xinyong Liu, Yuning Song, Erik De Clercq, Qingzhu Zhang, Srinivasulu Cherukupalli, Wen‐Ming Chen, Xinyong Liu, Wenjun Li, Zengjun Fang and Hao Xu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Molecular Biology and Progress in Polymer Science.

In The Last Decade

Peng Zhan

82 papers receiving 2.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fsp3: A new parameter for drug-likeness

2020 265 citations Xinyong Liu, Peng Zhan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peng Zhan China	23	799	766	495	345	234	87	2.1k
Rob Webster United Kingdom	17	203 0.3×	705 0.9×	527 1.1×	657 1.9×	200 0.9×	26	2.1k
Marco Radi Italy	29	1.4k 1.7×	981 1.3×	349 0.7×	210 0.6×	123 0.5×	97	2.5k
Reza Oliyai United States	13	434 0.5×	855 1.1×	327 0.7×	115 0.3×	123 0.5×	21	1.8k
Lars Petter Jordheim France	27	524 0.7×	1.7k 2.2×	597 1.2×	97 0.3×	370 1.6×	109	3.1k
Antonio Garofalo Italy	31	1.2k 1.5×	1.2k 1.6×	165 0.3×	110 0.3×	109 0.5×	119	3.2k
Yongseok Choi South Korea	22	392 0.5×	566 0.7×	308 0.6×	93 0.3×	173 0.7×	64	1.3k
V. L. Narayanan United States	24	890 1.1×	1.0k 1.3×	406 0.8×	223 0.6×	160 0.7×	68	2.2k
Aiming Sun United States	29	401 0.5×	947 1.2×	156 0.3×	84 0.2×	455 1.9×	42	2.1k
Dongwei Kang China	34	1.4k 1.7×	1.2k 1.6×	1.8k 3.7×	1.2k 3.6×	953 4.1×	151	3.7k
T. Eric Ballard United States	24	632 0.8×	924 1.2×	202 0.4×	37 0.1×	71 0.3×	40	1.9k

Countries citing papers authored by Peng Zhan

Since Specialization

Citations

This map shows the geographic impact of Peng Zhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Zhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Zhan more than expected).

Fields of papers citing papers by Peng Zhan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peng Zhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Zhan. The network helps show where Peng Zhan may publish in the future.

Co-authorship network of co-authors of Peng Zhan

This figure shows the co-authorship network connecting the top 25 collaborators of Peng Zhan. A scholar is included among the top collaborators of Peng Zhan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peng Zhan. Peng Zhan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhao, Fabao, Na Liu, Zhen Gao, et al.. (2025). Discovery of Brain-Penetrative Negative Allosteric Modulators of NMDA Receptors Using FEP-Guided Structure Optimization and Membrane Permeability Prediction. Journal of Chemical Information and Modeling. 65(2). 857–872. 1 indexed citations

Wang, Shuo, et al.. (2025). A patent review of hepatitis B virus core protein allosteric modulators (2019-present). Expert Opinion on Therapeutic Patents. 35(5). 441–461.

Tang, Kai, Guochao Wei, & Peng Zhan. (2024). Breaking the impossible: The evolutionary journey of lenacapavir, a long-acting anti-HIV drug. Chinese Chemical Letters. 36(7). 110500–110500. 2 indexed citations

Jing, Lanlan, Gaochan Wu, Fabao Zhao, et al.. (2024). Discovery of potent HIV-1 NNRTIs by CuAAC click-chemistry-based miniaturized synthesis, rapid screening and structure optimization. European Journal of Medicinal Chemistry. 277. 116772–116772. 4 indexed citations

Huang, Shiming, et al.. (2024). Clinical trial of arthroscopic debridement combined with functional exercise in the treatment of advanced knee osteoarthritis: A retrospective observational study. Journal of Back and Musculoskeletal Rehabilitation. 37(6). 1673–1683.

Kim, Meehyein, et al.. (2024). Jun12682, a potent SARS-CoV-2 papain-like protease inhibitor with exceptional antiviral efficacy in mice. Acta Pharmaceutica Sinica B. 14(9). 4189–4192. 3 indexed citations

Wang, Mei, Shujing Xu, Xiaoyu Shi, Edeildo Ferreira da Silva‐Júnior, & Peng Zhan. (2024). Solving the mysteries of urate transport: structural insights into GLUT9 and URAT1. SHILAP Revista de lepidopterología. 3(3). 1 indexed citations

Zhan, Peng, et al.. (2024). Multi-target Compounds against Trypanosomatid Parasites andMycobacterium tuberculosis. Current Drug Targets. 25(9). 602–619.

Zhang, Ying, et al.. (2023). Emerging drug design strategies in anti-influenza drug discovery. Acta Pharmaceutica Sinica B. 13(12). 4715–4732. 12 indexed citations

10.

Liu, Chuanfeng, Ying Zhang, Ping Li, et al.. (2023). Development of chalcone-like derivatives and their biological and mechanistic investigations as novel influenza nuclear export inhibitors. European Journal of Medicinal Chemistry. 261. 115845–115845. 3 indexed citations

11.

Gao, Shenghua, Fabao Zhao, Dongwei Kang, et al.. (2023). Discovery of novel sulfonamide substituted indolylarylsulfones as potent HIV-1 inhibitors with better safety profiles. Acta Pharmaceutica Sinica B. 13(6). 2747–2764. 10 indexed citations

12.

Jia, Ruifang, Jiwei Zhang, Fangyuan Shi, et al.. (2023). Discovery of N-substituted oseltamivir derivatives as novel neuraminidase inhibitors with improved drug resistance profiles and favorable drug-like properties. European Journal of Medicinal Chemistry. 252. 115275–115275. 6 indexed citations

13.

Zhang, Heng, Jing Li, Károly Tóth, et al.. (2023). Identification of Ebselen derivatives as novel SARS-CoV-2 main protease inhibitors: Design, synthesis, biological evaluation, and structure-activity relationships exploration. Bioorganic & Medicinal Chemistry. 96. 117531–117531. 4 indexed citations

14.

Xu, Shujing, Xinyong Liu, & Peng Zhan. (2022). SMIP-30, a potent and selective PPM1A inhibitor with potential to treat tuberculosis. Acta Pharmaceutica Sinica B. 12(12). 4519–4521. 3 indexed citations

15.

Jiang, Xiangyi, Chisa Kobayashi, Yujie Ren, et al.. (2022). Design, Synthesis, and Evaluation of a Set of Carboxylic Acid and Phosphate Prodrugs Derived from HBV Capsid Protein Allosteric Modulator NVR 3-778. Molecules. 27(18). 5987–5987. 4 indexed citations

16.

Zhang, Lina, Fenju Wei, Jiwei Zhang, et al.. (2022). Current medicinal chemistry strategies in the discovery of novel HIV-1 ribonuclease H inhibitors. European Journal of Medicinal Chemistry. 243. 114760–114760. 11 indexed citations

17.

Feng, Da, Xiaoying Zhang, Zhongxia Zhou, et al.. (2022). Disubstituted pyrimidine-5-carboxamide derivatives as novel HIV-1 NNRTIs: Crystallographic overlay-based molecular design, synthesis, and biological evaluation. European Journal of Medicinal Chemistry. 246. 114957–114957. 9 indexed citations

18.

Gao, Shenghua, Hongtao Xu, Steven De Jonghe, et al.. (2022). Identification of Polyphenol Derivatives as Novel SARS-CoV-2 and DENV Non-Nucleoside RdRp Inhibitors. Molecules. 28(1). 160–160. 6 indexed citations

19.

Gao, Shenghua, Fabao Zhao, Shujing Xu, et al.. (2022). Chemical space exploration around indolylarylsulfone scaffold led to a novel class of highly active HIV-1 NNRTIs with spiro structural features. European Journal of Medicinal Chemistry. 238. 114471–114471. 9 indexed citations

20.

Chen, Jing, Sen Ren, Dominik Duscher, et al.. (2019). Exosomes from human adipose‐derived stem cells promote sciatic nerve regeneration via optimizing Schwann cell function. Journal of Cellular Physiology. 234(12). 23097–23110. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact